Stocks/CURX

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

CURX

↓ PDF (Pro)
Curanex Pharmaceuticals Inc Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$0.35
-3.55%today
MKT CAP
$10M
-25.5% · 1Y
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership67.8%
Institutional Ownership0.0%
Short % of Float0.67%
Days to Cover0.0d
1 Week-16.3%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
HolderType% HeldValueΔ SharesAs of
UBS Group AGinstitution0.23%$0.00B+100.00%2025-09-30
Citadel Advisors Llcinstitution0.23%$0.00B+100.00%2025-09-30
Jane Street Group, LLCinstitution0.12%$0.00B+100.00%2025-09-30
Two Sigma Securities, LLCinstitution0.11%$0.00B+100.00%2025-09-30
Jump Financial, LLCinstitution0.10%$0.00B+100.00%2025-09-30
Geode Capital Management, LLCinstitution0.07%$0.00B+100.00%2025-09-30
Millennium Management Llcinstitution0.07%$0.00B+100.00%2025-09-30
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fundfund0.07%$0.00B+0.00%2025-10-31
Scientech Research LLC institution0.05%$0.00B+100.00%2025-09-30
Barclays Plcinstitution0.02%$0.00B+100.00%2025-09-30
Osaic Holdings Inc.institution0.02%$0.00B+100.00%2025-09-30
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Recent Alerts
No alerts yet for CURX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.